We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNA icon
351
CareDx
CDNA
$2.58B
$183K 0.01%
17,239
+7,074
+70% +$70.8K
RLAY icon
352
Relay Therapeutics
RLAY
$4.11B
$182K 0.01%
21,930
+4,444
+25% +$43.4K
CDMO
353
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$166K 0.01%
24,837
+4,488
+22% +$30.9K
ALLO icon
354
Allogene Therapeutics
ALLO
$698M
$166K 0.01%
+37,130
New +$155K
DCPH
355
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$162K 0.01%
+10,313
New +$159K
AVXL icon
356
Anavex Life Sciences
AVXL
$277M
$161K 0.01%
31,659
+19,271
+156% +$108K
OLMA icon
357
Olema Pharmaceuticals
OLMA
$899M
$158K 0.01%
+13,927
New +$180K
MNKD icon
358
MannKind Corp
MNKD
$1.27B
$157K 0.01%
34,596
-9,025
-21% -$35.4K
CRBU icon
359
Caribou Biosciences
CRBU
$174M
$132K 0.01%
25,586
+5,235
+26% +$32.3K
SMMT icon
360
Summit Therapeutics
SMMT
$11B
$127K 0.01%
+30,729
New +$122K
SIRI icon
361
SiriusXM
SIRI
$9.62B
$125K 0.01%
3,214
-90
-3% -$4.28K
MDXG icon
362
MiMedx Group
MDXG
$656M
$105K 0.01%
+13,622
New +$109K
TNGX icon
363
Tango Therapeutics
TNGX
$3.94B
$82.6K 0.01%
+10,398
New +$111K
ALEC icon
364
Alector
ALEC
$261M
$78.4K ﹤0.01%
13,025
+2,833
+28% +$18.5K
MRSN
365
DELISTED
Mersana Therapeutics
MRSN
$78K ﹤0.01%
+696
New +$69.2K
SCLX icon
366
Scilex Holding
SCLX
$38.2M
$50K ﹤0.01%
898
– –
BA icon
367
Boeing
BA
$166B
– –
-768
Closed -$200K
BABA icon
368
Alibaba
BABA
$296B
– –
-4,488
Closed -$348K
BIDU icon
369
Baidu
BIDU
$32.9B
– –
-4,578
Closed -$545K
BLUE
370
DELISTED
bluebird bio
BLUE
– –
-3,503
Closed -$96.7K
DAWN
371
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-12,618
Closed -$184K
DQ
372
Daqo New Energy
DQ
$926M
– –
-50,735
Closed -$1.35M
FUTU icon
373
Futu Holdings
FUTU
$17.4B
– –
-18,944
Closed -$1.03M
GPCR icon
374
Structure Therapeutics
GPCR
$3.38B
– –
-28,589
Closed -$1.17M
HSAI
375
Hesai Group
HSAI
$2.74B
– –
-170,914
Closed -$1.52M
12 13 14
15
16

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.